Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | KCNJ1 | P48048 | 8/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29118314 | 0.98 | NOTUM (0.39) | NOTUMMAPTF2KCNJ1ALDH1A1 | |
| Guanidine SCHEMBL7865811 | 0.89 | MAPT (0.40) | NOTUMMAPTF2KCNJ1ALDH1A1 | |
| SCHEMBL29224572 | 0.78 | L3MBTL1 (0.38) | NOTUMMAPTALDH1A1LMNAHTT | |
| SCHEMBL8688771 | 0.69 | KDM4E (0.35) | ALDH1A1 | |
| SCHEMBL19856445 | 0.65 | KCNJ1 (0.40) | NOTUMMAPTF2KCNJ1ALDH1A1 | |
| SCHEMBL29710932 | 0.65 | NOTUM (0.39) | NOTUMMAPTF2KCNJ1ALDH1A1 | |
| SCHEMBL29220900 | 0.65 | NOTUM (0.39) | NOTUMMAPTF2KCNJ1ALDH1A1 | |
| SCHEMBL2289284 | 0.62 | NOTUM (0.52) | NOTUMMAPTF2KCNJ1ALDH1A1 | |
| SCHEMBL9466419 | 0.62 | NPC1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL29238578 | 0.61 | ALDH1A1 (0.47) | NOTUMMAPTF2ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116925004-A | N10 chain-containing gas generating agent and synthesis method thereof | 南京理工大学 | 2023-10-24 | — | — | CN | claimed |
| US-20230322180-A1 | COMPRESSED PROPELLANT ELEMENT, METHOD OF MANUFACTURE THEREOF AND GAS GENERATOR COMPRISING PROPELLANT ELEMENT | ZF AIRBAG GERMANY GMBH (DE) | 2023-10-12 | — | — | US | claimed |
| US-20230219866-A1 | GAS GENERATING COMPOSITIONS AND METHODS OF USING | DEUTSCHE BANK TRUST COMPANY AMERICAS | 2023-07-13 | — | — | US | claimed |
| EP-2592073-B1 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND THEIR USE | AERPIO THERAPEUTICS INC (US) | 2017-08-30 | — | — | EP | claimed |
| US-9045380-B1 | Gas generating compositions | TK HOLDINGS INC. (US) | 2015-06-02 | — | — | US | claimed |
| US-8895563-B2 | Human protein tyrosine phosphatase inhibitors and methods of use | AERPIO THERAPEUTICS, INC. (US) | 2014-11-25 | — | — | US | claimed |
| EP-2041102-B1 | Human protein tyrosine phosphatase inhibitors and methods of use | AERPIO THERAPEUTICS INC (US) | 2014-11-12 | — | — | EP | claimed |
| US-20140249100-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS | AERPIO THERAPEUTICS INC. (US) | 2014-09-04 | — | — | US | claimed |
| EP-2624916-A2 | COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES | Aerpio Therapeutics Inc. (US) | 2013-08-14 | — | — | EP | claimed |
| EP-2592073-A2 | Human protein tyrosine phosphatase inhibitors and their use | Warner Chilcott Company, LLC (PR) | 2013-05-15 | — | — | EP | claimed |
| WO-2008002570-A2 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-03 | — | — | WO | claimed |
| US-20070299116-A1 | {4-[2-(5-methyl-[1,3,4]thiadiazol-2-ylamino)-2-(4-phenylthiazol-2-yl)-ethyl]phenyl}sulfamic acid; anticarcinogenic, antitumor, antidiabrtic agent; angiogenesis inhibitor; sarcoid, syphilis, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis | THE PROCTER & GAMBLE COMPANY (US) | 2007-12-27 | — | — | US | claimed |
| US-20070181236-A1 | Gas-generating pyrotechnical compositions and pyrotechnical compounds for automotive safety | SNPE MATERIAUX ENERGETIQUES (FR) | 2007-08-09 | — | — | US | claimed |
| EP-1713745-A2 | GAS-GENERATING PYROTECHNICAL COMPOSITIONS AND PYROTECHNICAL COMPOUNDS FOR AUTOMOTIVE SAFETY | SNPE Matériaux Energétiques (FR) | 2006-10-25 | — | — | EP | claimed |
| WO-2005077862-A2 | GAS-GENERATING PYROTECHNICAL COMPOSITIONS AND PYROTECHNICAL COMPOUNDS FOR AUTOMOTIVE SAFETY | SNPE MATERIAUX ENERGETIQUES (FR) | 2005-08-25 | — | — | WO | claimed |
| EP-1003696-B1 | IGNITION ENHANCEMENT COMPOSITION FOR AN AIRBAG INFLATOR | KEY SAFETY SYSTEMS INC (US) | 2005-03-30 | — | — | EP | claimed |
| US-6300498-B1 | Substituted ammonium salt of 1,5′-bitetrazole | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2001-10-09 | — | — | US | claimed |
| EP-1003696-A4 | IGNITION ENHANCEMENT COMPOSITION FOR AN AIRBAG INFLATOR | BREED AUTOMOTIVE TECH (US) | 2000-09-13 | — | — | EP | claimed |
| EP-1003696-A1 | IGNITION ENHANCEMENT COMPOSITION FOR AN AIRBAG INFLATOR | Breed Automotive Technology, Inc. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999008983-A1 | IGNITION ENHANCEMENT COMPOSITION FOR AN AIRBAG INFLATOR | BREED AUTOMOTIVE TECHNOLOGY, INC. (US) | 1999-02-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299116-A1 | {4-[2-(5-methyl-[1,3,4]thiadiazol-2-ylamino)-2-(4-phenylthiazol-2-yl)-ethyl]phenyl}sulfamic acid; anticarcinogenic, antitumor, antidiabrtic agent; angiogenesis inhibitor; sarcoid, syphilis, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis | DUSP15, PPP5C, DUSP1 | NOTUM 3923/4885MAPT 436/4885F2 4816/4885 |
| US-20140249100-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS | EPCAM, CD44, CDH1 | NOTUM 1289/4885MAPT 4288/4885F2 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.